Intent to Sole Source

The Department of the Interior's Interior Business Center has issued a Notice of Intent to Sole Source on behalf of the National Cancer Institute's Center for Cancer Research. The government intends to negotiate a firm-fixed-price noncompetitive acquisition with Bio-Rad for the purchase of one Automatic Droplet Generator and one QX600 Droplet Reader system. Bio-Rad has been identified as the original equipment manufacturer with exclusive capability to provide these mission-critical instruments and ensure the necessary system compatibility for the research operations. The equipment will be delivered to the National Cancer Institute in Bethesda, Maryland. This special notice was posted on April 2–3, 2026, with a due date of April 20, 2026.

The objective of this acquisition is to replace aging droplet digital PCR equipment and ensure continued operation of the Center for Cancer Research's Genomics Core. Interested parties must submit capability statements electronically by 10:00 A.M. ET on Monday, April 20, 2026, to Contracting Officer Bridgette Ornelas and Contract Specialist Desmond Harris. Submissions must be in Microsoft Office-compatible format or Adobe Acrobat, not exceed 10 pages with minimum 11-point font, and not exceed 8 MB in file size, with proprietary information clearly marked. While Bio-Rad is the identified sole source, the government reserves the right to conduct a competitive acquisition or issue a Request for Quote based on capability statements received. The contractor must complete delivery no later than 12 weeks after contract award.